The Sequencing laboratory operates under Good Laboratory Practice/ Good Clinical Laboratory Practice (GLP/GCLP) standards and provides services to clients in the academic, industrial, and pharmaceutical communities. All operations are conducted following Standard Operating Procedure (SOP) and all experiments workflows are documented in a Laboratory Information Management System (LIMS). The Pharmacogenomics Centre is equipped with the Illumina NovaSeq 6000 and MiSeq technologies giving a broad range of experimental design possibilities from whole genome sequencing to small targeting sequencing. As part of its core expertise, the Pharmacogenomics Centre posses a Bioinformatics team allowing a complete service from the data analysis, interpretation to data reporting.

The Pharmacogenomics Centre offers sequencing project evaluation and planning.

Sequencing Core Expertise

  • Targeting Sequencing
    • PCR Based Enrichment
      • Agilent HaloPlex Custom (link)
      • CleanPlex® Amplicon (link)
        • CleanPlex® SARS-CoV-2 Panel (link)
        • CleanPlex® UMI CHIP panel
          • DNMT3A, TET2, ASXL1, PPM1D, TP53, SF3B1, SRSF2, CBL, JAK2, GNAS, GNB1
  • Whole Genome Sequencing
  • Whole Exome Sequencing
    • Agilent SureSelect Human All Exome (link)
    • Roche-NimbleGen SeqCap EZ Exome (link)

Sequencing Technologies

  • MiSeq
    • V2 chemistry: up to 8.5 GB of data or 30 Million billion PE reads per Flow Cell
    • V3 chemistry: up to 15 GB of data or 50 Million billion PE reads per Flow Cell
  • NovaSeq 6000
    • V1.5 chemistry: up to 3000 Gb of data or 20 Million billion PE reads per Flow Cell


Ian Mongrain, M.Sc.
Directeur des opérations/Director of operations

Beaulieu-Saucier Pharmacogenomics Centre
Montreal Heart Institute, office S-2050
5000, Belanger East, Montreal
Qc, Canada, H1T1C8

Office: 514-670-7670, 7716
CA/USA: 1-855-670-7670, 7716
Fax: +1-514-670-7671